文献速递糖尿病

使用生物标志物与连续血糖监测检测高血糖的比较

Detecting Hyperglycemia Using Biomarkers Versus Continuous Glucose Monitoring.
PubMed 文献 · Diabetes Care · 2025-01-01

该研究为552名2型糖尿病成人的汇总横截面分析,评估糖化白蛋白、果糖胺、1,5-脱水葡萄糖醇(1,5-AG)和糖化血红蛋白(HbA1c)与连续血糖监测(CGM)高血糖指标的一致性。结果显示糖化白蛋白和果糖胺与CGM平均血糖的相关性及检测目标范围内/高于范围时间的能力与HbA1c相似,1,5-AG相关性较弱。

要点

  • 糖化白蛋白和果糖胺与CGM平均血糖的相关性(r=0.64)低于HbA1c(r=0.72),但检测目标范围内/高于范围时间的c统计量与HbA1c相似(0.85-0.94)。
  • 1,5-AG与CGM平均血糖相关性较弱(r=0.46)。
  • 糖化白蛋白和果糖胺可作为高血糖的替代测量指标。

核心结论

  • 糖化白蛋白和果糖胺与CGM定义的高血糖指标的相关性与HbA1c相似,三者检测高于范围和范围内时间的能力相似,结果支持糖化白蛋白和果糖胺作为高血糖的替代测量指标。

研究设计与样本

  • 汇总横截面分析,纳入552名年龄30-97岁的2型糖尿病成人,参与者佩戴CGM长达2周,评估血液生物标志物与CGM定义的高血糖和血糖控制指标之间的一致性。

主要发现

  • 552名参与者平均年龄74岁,53%为女性,36%为黑人,CGM平均血糖的中位数为132 mg/dL,平均84%的时间在范围内(70-180 mg/dL)。
  • CGM平均血糖与HbA1c强相关(r=0.72),与糖化白蛋白(r=0.64)和果糖胺(r=0.64)相关,与1,5-AG弱相关(r=0.46)。
  • 高于范围时间(>180 mg/dL)的结果与平均血糖相似。
  • 糖化白蛋白和果糖胺在检测目标范围内和高于范围时间方面与HbA1c表现相似(c统计量范围为0.85至0.94)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the concordance of glycated albumin, fructosamine, 1,5-anhydroglucitol (1,5-AG), and hemoglobin A1c (HbA1c) with continuous glucose monitor (CGM) metrics of hyperglycemia and glycemic control in a diverse population of adults with type 2 diabetes. RESEARCH DESIGN AND METHODS: This was a pooled cross-sectional analysis of 552 adults, ages 30-97 years old, with diabetes. Participants wore a CGM for up to 2 weeks, and we evaluated the agreement between blood biomarkers (glycated albumin, fructosamine, and 1,5-AG) with CGM-defined metrics of hyperglycemia and glycemic control. RESULTS: Of the 552 participants (mean age 74 years, 53% women, 36% Black), the median of mean CGM glucose was 132 mg/dL, and participants spent on average 84% of their time in range (70-180 mg/dL). CGM mean glucose was strongly related to HbA1c (r = 0.72), glycated albumin (r = 0.64), and fructosamine (r = 0.64) but weakly related to 1,5-AG (r = 0.46). Results were similar for time above range (>180 mg/dL). Glycated albumin and fructosamine performed similarly to HbA1c in the detection of target time in and above range (c-statistics ranged from 0.85 to 0.94). CONCLUSIONS: Glycated albumin and fructosamine had similar associations with CGM-defined metrics of hyperglycemia compared with HbA1c. These three biomarkers performed similarly in the detection of time above range and in range. Our results provide evidence for the utility of glycated albumin and fructosamine as alternate measures of hyperglycemia.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Daya NR, Fang M, Shin JI, et al. Detecting Hyperglycemia Using Biomarkers Versus Continuous Glucose Monitoring. Diabetes Care. 2025. PMID: 40504990. doi:10.2337/dc25-0595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。